Human microbiome: general information and clinical significance of digestive canal eubiosis
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 5
Abstract
The resent investigations demonstrate the key role of the human microbiome in the formation of homeostasis, highlight the microbiota effects on a human immune system, its development and physiology, including organo- and morphogenesis, as well as metabolism. According to the current data obtained with the use of metagenomic, metatranscriptomic, metaproteomic and metabolic approaches, the number of microorganisms that inhabit the human body is 10 times greater than the number of cells in a human body. The total microbiome contains more than 5 million genes, which is ten times greater than the human genome. The billions of bacteria that live in our body can significantly affect the risk of chronic diseases, including atherosclerosis, infectious endocarditis, systemic and autoimmune diseases, allergic diseases, diabetes, obesity, gastrointestinal pathology, oncology diseases and some mental disorders (attention deficit disorder, schizophrenia, bipolar disorder, autism syndrome, depression, etc.). The state of dynamic equilibrium between the macro-organism, the micro-organisms that inhabit it and the environment — eubiosis is important. This review provides general information on the major constituents of human microbiome biotopes and the clinical significance of digestive tract eubiosis, discusses promising areas of research and correction of microbiocenosis. The most studied, numerical and significant biotope, the functions of which are practically approaching the functions of the liver, are considered — the gut microbiome and its modern methods of research. The expediency of prescribing probiotic agents in a number of chronic diseases to maintain eubiosis is substantiated. A promising area is the study of different biotopes of human microbiome using modern diagnostic methods, which will better predict the risks of chronic diseases and bring the therapeutic approach closer to personalized medicine.
Authors and Affiliations
G. D. Fadieienko, Yа. V. Nikiforova
Keywords
Related Articles
- EP ID EP675478
- DOI 10.30978/MG-2019-5-65
- Views 130
- Downloads 0
Helicobacter pylori infection and acid-related diseases against the background of metabolic-associated conditions: mechanisms of development and management
The author presents data on the role of H. pylori infection in the initiation and progression of the changes in metabolic status of patients with type 2 diabetes mellitus (DM-2), insulin resistance, obesity, cardiovascul...
Investigation of the effects of the blood plasma levels of C16 ceramides on the course of non-alcoholic fatty liver disease
Objective — to investigate the dependence of the blood plasma levels of C16 ceramides on the degree of liver steatosis in patients with nonalcoholic fatty liver disease (NAFLD) based on the results of steatomometry in co...
How pharmacokinetics of 5-ASA preparations affects their efficacy?
_
The lactase gene polymorphism and the course of chronic pancreatitis in patients with essential hypertension
Objective — to determine the polymorphism of the 13910 C/T marker of the LCТ gene associated with the combined course of chronic pancreatitis (ChP) and hypertensive disease (HD). Materials and methods. The examinations i...
Vegetative accompaniment of the combined course of gastroesophageal reflux disease in young patients with autoimmune thyroiditis
Objective — to establish the presence of autonomic dysfunction and to assess the frequency and severity of its manifestations in patients with autoimmune thyroiditis (AIT) and gastroesophageal reflux disease (GERD) with...